Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56Lck inhibitors

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

A series of substituted 2-(aminoheteroaryl)-thiazole-5-carboxamide analogs have been synthesized as novel, potent inhibitors of the Src-family kinase p56Lck. Among them, compound 2 displayed superior in vitro potency and excellent in vivo efficacy.

Knowledge Graph

Similar Paper

Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56Lck inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine—a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays
Bioorganic & Medicinal Chemistry Letters 2007.0
Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation
Journal of Medicinal Chemistry 2008.0
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases
Bioorganic & Medicinal Chemistry Letters 2004.0
Thiazolyl N-benzyl-substituted acetamide derivatives: Synthesis, Src kinase inhibitory and anticancer activities
European Journal of Medicinal Chemistry 2011.0
Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-β type1 receptor kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part II
European Journal of Medicinal Chemistry 2013.0
Synthesis and biological evaluation of 5,6-diarylimidazo[2.1-b]thiazole as selective COX-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 1997.0
Structure–activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0